Position in TRVI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$39,113,059
New position
Shares Held
2,097,215
first reported quarter
Ownership
1.47%
of shares outstanding
% of Portfolio
2.38%
of 13F equity value
Holder Rank
#20
of 216 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026First Light Asset Management, LLC holds $573,690,960 across 11 Biotechnology names. TRVI ranks #7 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
930,289 | $123,477,258 | |
| 2 | PVLA |
Palvella Therapeutics, Inc.
|
771,901 | $117,961,910 | |
| 3 | ELVN |
Enliven Therapeutics, Inc.
|
1,360,750 | $69,058,062 | |
| 4 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
1,360,866 | $50,923,605 | |
| 5 | EWTX |
Edgewise Therapeutics, Inc.
|
1,095,171 | $44,496,797 | |
| 6 | ANAB |
Anaptysbio, Inc
|
582,004 | $39,285,270 | |
| 7 | TRVI |
Trevi Therapeutics, Inc.
This page
|
2,097,215 | $39,113,059 | |
| 8 | SEPN |
Septerna, Inc.
|
963,260 | $32,259,577 |
All Filings in TRVI
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,113,059 | 2,097,215 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||